Search results for "Anticoagulation"

Results 51 - 60 of about 426 for "Anticoagulation".

Table 8-2 Recommendations for Duration of Anticoagulation Condition

Table 1. Risk factors for venous thromboembolism. Acquired Inherited. Age >50 Factor V Leiden Surgery Prothrombin gene mutation (G20210A) Trauma Antithrombin deficiency Immobility Protein C deficiency Cancer Protein S deficiency Estrogens,
January 2017

In the News

The patient's baseline anticoagulant (warfarin vs. dabigatran) wasn't associated with outcome after temporary interruption. ... Two large randomized, placebo-controlled trials are currently underway that should help further inform periprocedural
March 2015

Approvals for an oral anticoagulant, weight-loss device, and generic esomeprazole

Details on the latest recalls, warnings, and approvals.
April 2015

NOACs recommended instead of warfarin for some afib patients, guideline states

The non-vitamin K oral anticoagulants (NOACs) dabigatran, rivaroxaban, apixaban, and edoxaban are recommended over warfarin in eligible patients with atrial fibrillation, according to one of several recommendations in an updated ... 2. DS. 2. -VASc score
February 2019

Inpatient mortality from major bleeds lower in patients on DOACs than warfarin

Intracranial hemorrhages, especially subdural hematomas, comprised a higher proportion of major bleeding in patients on warfarin, while those on direct oral anticoagulants (DOACs) had a higher proportion of gastrointestinal bleeds. ... A recent cohort
March 2017

Dabigatran or warfarin?

The new anticoagulant requires less monitoring, and research indicates a lower stroke or bleeding risk. ... a fully loaded anticoagulant that will be additive for hemorrhagic events,” he said.
March 2011

Afib initiative strives to close a quality gap

think about the patient holistically and look at atrial fibrillation and the lack of anticoagulation as an opportunity for improvement,” Dr. ... Of course, simply prescribing an anticoagulant when it's needed is not sufficient.
August 2012

Recent Research

mitral valve involvement (HR, 1.29) or if they received anticoagulant therapy (HR, 1.31). ... Based on these results, it seems advisable to avoid anticoagulant therapy in patients with these other risk factors, the study authors concluded.
July 2013

Redesigning anticoagulation clinics

Anticoagulation clinics that have historically monitored patients receiving warfarin therapy are broadening their focus to include the direct oral anticoagulants—dabigatran, rivaroxaban, apixaban, edoxaban—and in some cases are even zeroing
September 2016


Patients who received brain imaging, carotid artery imaging, antihypertensive intensification, statins, antithrombotics, and anticoagulation for atrial fibrillation after transient ischemic attack (TIA) or nonsevere ischemic stroke had lower risk of
July 2019

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next